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How Did Zika Virus Emerge in the Pacific Islands and Latin America?
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Pathologies Virales (EPV: Aix-Marseille Université-IRD 190-INSERM 1207-EHESP), Marseille, Franceh; Institut Hospitalo-Universitaire Méditerranée Infection, APHM Public
Hospitals of Marseille, Marseille, Francei

ABSTRACT The unexpected emergence of Zika virus (ZIKV) in the Pacific Islands and Latin America and its association with
congenital Zika virus syndrome (CZVS) (which includes microcephaly) and Guillain-Barré syndrome (GBS) have stimulated
wide-ranging research. High densities of susceptible Aedes spp., immunologically naive human populations, global population
growth with increased urbanization, and escalation of global transportation of humans and commercial goods carrying vectors
and ZIKV undoubtedly enhanced the emergence of ZIKV. However, flavivirus mutations accumulate with time, increasing the
likelihood that genetic viral differences are determinants of change in viral phenotype. Based on comparative ZIKV complete
genome phylogenetic analyses and temporal estimates, we identify amino acid substitutions that may be associated with increased viral epidemicity, CZVS, and GBS. Reverse genetics, vector competence, and seroepidemiological studies will test our
hypothesis that these amino acid substitutions are determinants of epidemic and neurotropic ZIKV emergence.

Z

ika virus (ZIKV) was first described in the African forests,
where it circulates between nonhuman primates and sylvatic
mosquitoes (1). More than 60 years after its discovery, fewer than
20 human infections had been reported. The first ZIKV epidemic
occurred in Yap, Federated States of Micronesia, Pacific, in 2007
(2). Based on a serological survey, 73% of the inhabitants were
infected. ZIKV then disappeared epidemiologically until a large
outbreak occurred in French Polynesia (FP) in 2013 to 2014.
The outbreak was the first in which congenital Zika virus syndrome (CZVS), Guillain-Barré syndrome (GBS), and non-vectorborne transmission (materno-fetal, sexual, and posttransfusion)
occurred (1, 3). Retrospectively, cases of microcephaly were reported in the offspring of 1% of women calculated to have been
infected in their first trimester of pregnancy during the FP outbreak (4). Subsequently, ZIKV continued to spread in the Pacific
region (1) and emerged in the Americas in 2015. The emergence
was associated with a dramatic increase in microcephaly (5–7), a
manifestation of the congenital Zika virus syndrome (CZVS),
leading WHO to declare a global health emergency. Concomitantly, the number of infected visitors returning from the Pacific
and Latin America to their homelands in North America, Europe,
Asia, and Australasia was increasing, thus extending the risk for
ZIKV in areas in which the Aedes ZIKV-competent mosquito is
present.
Two ZIKV lineages have been described: African and Asian.
Strains that emerged in the Pacific Islands and Latin America belong to the Asian lineage. In late 2015, a ZIKV outbreak due to an
Asian lineage strain was also associated with cases of microcephaly. It occurred on Cape Verde off the coast of Africa (1). These
data suggest that the severe neurological complication of ZIKV
infections (GBS and CZVS) are associated with the strains that
emerged in French Polynesia and subsequently spread to the Pacific Islands and Latin America and back to Africa at least to a
coastal island.
How did ZIKV emerge from its sylvatic forest existence to
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cause major epidemics throughout the Pacific and the Americas?
Similar to dengue virus (DENV), ZIKV had the potential to adapt
from a sylvatic cycle involving sylvatic mosquitoes and nonhuman
primates to an urban cycle involving urban/suburban mosquitoes
and humans (1).
One possibility is that the emergence of ZIKV is simply a consequence of the increasing global human population, increasing
population of competent mosquito vectors, increasing urbanization, and increasing global transportation of commercial goods.
Lack of ZIKV-specific population immunity was almost certainly
a contributing factor to the emergence of ZIKV. Additionally, the
possibility of immune enhancement arising from cross-reactions
with related viruses such as dengue virus cannot be ignored (8).
However, we share the view of Musso and Gubler that genetic
changes are the most likely explanation for the dramatic emergence and neuroinvasiveness of ZIKV (1). This concept is supported by observations that genetic changes associated with vector
specificity and epidemic potential in chikungunya virus (9) and
increased virogenesis in West Nile virus (10) have been reported.
Accordingly, to study the possible effect of nonsynonymous mutations in the open reading frame and changes in the 5= and 3=
untranslated regions (UTRs), we investigated the evolution of
ZIKV through analysis of an extensive range of complete ZIKV
genomic sequences. We identify amino acid changes that arose
progressively throughout the viral genome as the virus emerged
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out of Africa and gradually dispersed across Asia, the Pacific, and
Latin America and the more restricted changes that occurred in
the untranslated regions. Importantly, we highlight and discuss
specific amino acid substitutions that are directly associated with
the appearance of the altered epidemiological and neurotropic
characteristics of epidemic Pacific/Latin American ZIKV.
Methods. To explore the temporal evolution of ZIKV, representative
and robust complete ZIKV sequences available as of 29 May 2016 were
retrieved from GenBank (http://www.ncbi.nlm.nih.gov/genbank). At the
time, only one isolate was available from French Polynesia (FP). To study
the possibility that some FP isolates had the mutation M/T2634V first
documented in the Latin American strains, an additional 13 isolates from
various times and places in the FP outbreak were sequenced in house. The
in-house next-generation sequencing was performed with the Ion PGM
sequencer (Thermo, Fisher Scientific), and analyses were conducted with
the CLC Genomics Workbench software. RNA was extracted from serum
or cell supernatant medium using the EZ1 Mini virus 2.0 kit and the EZ1
advanced XL machine (both from Qiagen). Complete virus genomes were
amplified in 3 or 12 fragments using specific sets of primers with the
Superscript III one-step reverse transcription-PCR (RT-PCR) Platinum
TaqHifi kit (Thermo, Fisher Scientific).
Two alignments were constructed using Mafft v.7.266, keeping the
reading frame consistent with amino acid positions: one alignment (see
Data Set S1 in the supplemental material) contained only Asian, Pacific,
and Latin American ZIKV (n ⫽ 67 sequences), and the other alignment
(see Data Set S2 in the supplemental material) also included African ZIKV
(n ⫽ 84 sequences). In addition, separate alignments were constructed for
the 5=- and 3=-UTR regions (see Data Sets S3 and S4 in the supplemental
material) for those isolates for which the UTRs were available. Evolutionary rates were estimated using BEAST 1.8.3. After model testing, all analyses were run with the SRD06 codon-partitioned model using the general
time reversible (GTR) nucleotide substitution model with gamma distribution, a strict molecular clock with a continuous-time Markov chain
(CTMC) prior, and a Bayesian skyline coalescent tree prior with a
piecewise-constant demographic model. To ensure mixing of individual
chains and sufficient effective sample size (⬎100), each data set was run
three times for 100 million generations, sampling every 10,000 generations. After discarding 10% burn-in for each run, consensus files for each
data set were produced using LogCombiner and TreeAnnotator (BEAST
package). Consensus trees were then viewed and annotated in FigTree
1.3.1 (http://tree.bio.ed.ac.uk/software/figtree/). All computations were
performed at the CIPRES web portal (11). The numbers of unique stepwise amino acid changes in the different clades were checked visually and
compared in the combined African and non-African alignments using
AliView v1.18 (12).
Results. Two dated phylogenetic trees were constructed, and they produced identical topologies for the named key nodes. The first tree (Fig. 1)
displays the African viruses in a collapsed format and also includes Asian,
Pacific, and Latin American ZIKV isolates (Fig. 1). For the second tree
(not shown), the African viruses were excluded. The boxes in Fig. 1 connected by dashed lines to the tree identify all amino acid substitutions that
occurred beyond each branch (identified as nodes A to G). The 9 highlighted amino acids identified in boxes 2, 3, 4, 6, and 7 identify substitutions that will be discussed in the context of epidemic emergence of ZIKV
and GBS/microcephaly. The conclusions drawn from the tree suggest that
the African and Asian strains diverged from their ancestor around 1834
(95% highest posterior density interval [HPD], November 1814 to August
1852 [formatted throughout by year-month as “1814-11 to 1852-08”])
(node 1). The most recent common ancestor of the sylvatic African ZIKV
emerged around 1889 (95% HPD, 1879-03 to 1898-01) (node 2). Furthermore, our analyses and supporting data extend the accumulating evidence
(13, 14) that the Asian ZIKV emerged around 1946 (95% HPD, 1942-04 to
1953-10) based on the analysis, including African and Asian viruses, or
around 1966 (95% HPD, 1964-02 to 1966-07), based on analysis including only Asian viruses. Importantly, none of the identified substitutions
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(Fig. 1, box 1) was accompanied by a change in the sylvatic tendency of the
Asian strain isolated in Malaysia.
The first recorded dispersion of ZIKV out of Africa and Asia was to
Yap Island (node B). This resulted in an explosive outbreak of ZIKV
infection involving 73% of the immunologically naive population. However, as far as is known, this strain did not disperse further. Six years later,
another epidemic Asian strain was identified in FP, documenting for the
first time an association with microcephaly and GBS (3, 4, 15, 16). Based
on the available phylogenetic data, it was considered possible that an FP
strain was the source of the Latin American outbreaks of ZIKV disease
(17). These authors identified 5 amino acid substitutions in the ZIKV prM
protein that led them to predict major structural change in this protein.
Nevertheless, the tree (Fig. 1) shows that 4 of these substitutions (at amino
acid positions 143, 148, 157, and 158 of the prM protein) occurred in the
Malaysian strain of ZIKV, which, in common with African ZIKV, caused
only sporadic infections. The fifth of the prM substitutions, 153, did not
occur until after node A, at which point all isolates, with the exception of
the Philippine strain, were associated with epidemic spread.
Node B also identifies the point beyond which the ZIKV E protein
receptor VGD changed to VGE via the amino acid substitution D683E. In
general, the viral receptor plays an essential role in epidemic spread. This
concept is supported by studies with a genetically engineered dengue 2
virus (DENV2) receptor loop (VEPG), which show a direct correlation
between the receptor sequence and the ability of DENV-2 both to infect
mammalian cells and to be transmitted by Aedes aegypti (18). Two additional and potentially important E protein amino acid substitutions,
T777M (TM2; node C) and V763M (TM1; node D), were identified.
These amino acids associate with the transmembrane (TM) region of
infected cells and may play an active role in maintaining stability of the
pH-induced trimeric E protein and also in mediating membrane fusion
(19).
However, the Philippine and Micronesian isolates retained the African
TM1 and TM2 amino acids (V763 and T777). The Cambodian isolate
(node C) retained the African V763 TM1 amino acid but acquired the
Asian 777M TM2 amino acid. The Thailand virus isolate identified by
node D retained the Asian 777M and acquired the Asian amino acid substitution 763M and the second Thailand isolate identified by node E,
retained the Asian 777M and 763M but in addition acquired Y2086H
(Fig. 1). Thus, the Malaysian, Micronesian, Philippine, Cambodian, and
Thai viruses may represent the final progressive evolutionary stages that
endow ZIKV with epidemicity before the critical substitution that appears
to coincide with emergence of neurotropic ZIKV in FP.
The first appearance of a French Polynesian virus in the tree is identified by node F. Node F1 identifies a branch with 3 Samoan viruses and 6 FP
viruses, and node F2 identifies another branch with 5 FP viruses. Node F3
distinguishes a branch with 2 more FP viruses, which are the most closely
related FP viruses to the Latin American viruses, identified by node G.
Thus, nodes F, F1, F2, and F3 define 14 FP and 3 Samoan viruses that
evolved in FP/Samoa over a period of less than 3 years. Note that nodes F1
to F3 are distinguished only by synonymous and sequence-specific nonsynonymous mutations.
Node F identifies the evolutionary point of emergence of epidemic
neurotropic ZIKV, and this coincides precisely with the appearance of the
amino acid substitution S139N in both the French Polynesian and Samoan isolates (Fig. 1, nodes F and F1). Recognition of the presence of
ZIKV in human semen also coincides with the appearance of the S139N
substitution. However, this may reflect more intensive study of ZIKV after
its discovery in FP (20).
Amino acid 139 is in the ZIKV M protein, a transmembrane (TM)
protein. While the function of this amino acid has not been defined for
ZIKV, in DENV2 the equivalent amino acid is involved in the acid pHmediated viral surface maturation process (21). Thus, all ZIKV isolates
from FP onwards possess a VGE receptor sequence via the substitution
D683E, the E protein TM1/TM2 substitutions (V763M/T777M), and the
closely associated M protein TM modification (S139N).
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FIG 1 ZIKV phylogeny of African-Asian/Pacific and Latin American virus isolates, including mapping of amino acid substitutions. Dashed boxes show
positions of amino acid substitutions relative to the open reading frame of ZIKV NC_012532.1, and dashed lines indicate the branch positions in the tree at which
amino acid substitutions occurred. Amino acid substitutions of specific interest are highlighted in the boxes. The 5=- and 3=-UTR positions refer to the number
of nucleotide positions before the start codon and after the stop codon, respectively. For clarity, the tree displays all Pacific virus branches in blue and all Latin
(Continued)
September/October 2016 Volume 7 Issue 5 e01239-16

®

mbio.asm.org 3

Opinion/Hypothesis

TABLE 1 Estimated times of origin and evolutionary rates of Zika virusesa
Only Asian genomesb
Node

tMRCA (yr-mo)

1, African ZIKV/Asian ZIKV
2, African ZIKV
A, Malaysia 1966/other ZIKV
B, Philippines-Micronesia/other ZIKV
C, Cambodia/other ZIKV
D, Thailand/other ZIKV
E, Thailand/other ZIKV
F, PI/PI-American ZIKV
F1, PI/PI-American ZIKV
F2, PI/PI-American ZIKV
F3, PI/American ZIKV
G, American ZIKV

1966-01
2001-09
2004-11
2008-01
2010-04
2013-02
2013-05
2013-06
2013-10
2013-11

African and Asian genomesc
95% HPD (yr-mo)

tMRCA (yr-mo)

95% HPD (yr-mo)

1964-02–1966-07
2000-08–2002-09
2003-10–2005-10
2007-02–2008-11
2009-07–2011-02
2012-10–2013-05
2013-02–2013-07
2013-04–2013-11
2013-08–2013-11
2013-10–2014-02

1834-08
1889-02
1948-03
1994-05
1999-02
2003-10
2007-03
2011-12
2012-04
2012-07
2012-10
2012-11

1814-11–1852-08
1879-03–1898-01
1942-04–1953-10
1991-08–1996-11
1997-12–2001-04
2001-11–2005-06
2005-10–2008-08
2011-03–2012-07
2011-08–2012-10
2012-01–2012-12
2012-03–2013-02
2012-05–2013-04

a

tMRCA, time to most recent common ancestor; MER, mean evolutionary rate; HPD, highest posterior density interval; PI, Pacific Islands.
MER, 1.20 ⫻ 10⫺3; 95% HPD, 1.09 ⫻ 10⫺3 to 1.31 ⫻ 10⫺3.
c MER, 6.30 ⫻ 10⫺4; 95% HPD, 5.48 ⫻ 10⫺4 to 7.10 ⫻ 10⫺4.
b

Node G defines the point at which the substitution M/T2634V arises.
Thus, the tree shows clearly that GBS and microcephaly, which were first
reported in FP, arose following the S139N substitution in the ZIKV M
protein. None of the FP isolates had the M/T2634V substitution found in
the Latin American isolates. Although it will require further verification,
the substitution most likely arose after ZIKV escaped the Pacific. Whether
or not the M/T2634V substitution contributed to the recognized increased incidence of microcephaly in Latin America compared with the
Pacific is a matter for conjecture until further relevant virus isolates become available or experimental evidence is obtained.
Did the five unique amino acid substitutions defined above—i.e.,
D683E (box 2), T777M (box 3), V763M (box 4), S139N (box 6), and
M/T2634V (box 7)— have an impact on mosquito vector competence of
epidemic ZIKV and increased ZIKV neurotropicity? These questions will
be investigated using reverse genetics methods combined with vector
competence and seroepidemiological studies.
The acquisition of four additional amino acid substitutions, including
one in the NS4B protein (A/G2283S) and three in the NS5 protein (A/
T3046I, G/R3107K, and R/S3167N), distinguishes African/Malaysian
from other non-African ZIKVs (Fig. 1, box 2). These may have perturbed
the intracellular interferon type I pathway (22). Additionally, as components of the viral replicative complex, these unique substitutions may
contribute to enhanced viral replication (21, 23).
Comparative analysis of the 5= and 3= termini that form secondary
structures in the untranslated regions (UTRs) of the ZIKV genome revealed differences between African and all other ZIKV isolates studied
(Fig. 1, box 1; see Data Sets S3 and S4; see also Fig. S1 and S2). However,
since all of these changes preceded the dispersion of ZIKV to both Micronesia and separately the Pacific region further east, they are unlikely to
have been primary determinants of ZIKV epidemicity, although they may
make a supplementary contribution. Another factor, not revealed by current analyses, is the influence of defective interfering virus particles. In
DENV, such particles have been associated with increased epidemic potential (24).
Estimated mean evolutionary rates (MERs) and times to most recent
common ancestor (tMRCA) based on strict molecular clock estimates,
using trees that include or exclude African viruses, are also presented

(Table 1; see Data Sets S1 and S2 in the supplemental material). Estimated
MERs for the tree that included African viruses (6.30 ⫻ 10⫺4; 95% HPD,
5.5 ⫻ 10⫺4 to 7.1 ⫻ 10⫺4) were lower than those for the tree with African
viruses excluded (1.20 ⫻ 10⫺3; 95% HPD, 1.1 ⫻ 10⫺3 to 1.3 ⫻ 10⫺3).
Divergence of African and Asian ZIKV from a most recent common ancestor occurred around 1834 (95% HPD, 1814-11 to 1852-08). Subsequently there was a significant increase in the mean evolutionary rate of
the Pacific/Latin American variants of ZIKV, an observation consistent
with marked increase in virus transmission and turnover accompanying
the massive island and urban outbreaks. tMRCA estimates indicate that
the introduction of ZIKV into the Americas (Fig. 1, node G) occurred in
November 2013 (95% HPD, 2013-10 to 2014-02). Although the timing is
not significantly different from December 2013 (95% HPD, 2013-08 to
2014-04) of a previous estimate (13), the window of introduction is narrowed.
Our phylogenetic and comparative amino acid analyses revealed four
unique amino acid substitutions: one (D683E [box 2]) was located in the
viral receptor site, two (T777M [box 3] and V763M [box 4]) were located
in the viral envelope protein, and the final but possibly the most critical
one (S139N [box 6]) was located in the M protein. These amino acids
clearly play important roles in virus attachment entry, release, or maturation of the virus during the infectious process. Thus, three unique amino
acid substitutions directly associated with virus infection and transmission efficiency occurred just prior to the emergence and widespread dispersal of the highly epidemic and neurotropic ZIKV. The appearance of
the membrane protein substitution S139N coincided precisely with the
appearance of GBS and CZVS in FP. While this does not prove cause and
effect, it appears to be more than a coincidence. Another unique substitution, in the NS5 protein of ZIKV (M/T2634V [box 7]) was identified in
all Latin American viruses and may also impact neurotropicity since the
relative rate of CZVS increased significantly in Brazil compared with FP.
Other substitutions in the prM and E glycoproteins could either be
compensatory or could alter virus characteristics, such as hydrophilicity
and charge. As reported for DENV mutants, the ZIKV mutants show
efficiency for producing neurovirulence (25) and adsorption-mediated
endocytosis (AME). (AME depends on electrostatic/hydrophobic interactions between the virion and cell surface [26].)

Figure Legend Continued
American virus branches in red. Red circles highlight virus sequences that were retrospectively associated with CZVS. Posterior probability support values were
identical except for node F1, which were 0.92 and 0.98, respectively, for the analyses that included or excluded the African lineages (Fig. 1, nodes 1 to 2 and A to
G). Accession numbers for African genomes used in one of the analyses but not shown in the figure are as follows: HQ234498.1, DQ859059.1, KU720415.1,
LC002520.1, NC_012532.1, AY632535.2, KU963573.1, KF268949.1, KF268948.1, KF268950.1, KU963574.1, HQ234501.1, KU955595.1, KU955592.1,
KU955591.1, KF383116.1, and KX198134.1.
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The emergence of ZIKV and its widespread dispersion throughout the
tropics and subtropics have undoubtedly been influenced by increasing
human mobility, urbanization, and failure to reduce the spread and expanding population density of ZIKV Aedes species vectors. The recent
discovery that ZIKV is significantly more thermostable than DENV may
also contribute to its success as an epidemic virus through its ability to
reproduce to higher levels of viremia and to resist inactivation under
unfavorable environmental conditions (27).
The use of reverse genetics, vector competence studies, and seroprevalence analyses to gain an understanding of the epidemic potential of ZIKV
will enable the validity of our observations and hypotheses to be tested
both in vitro and in vivo.
Accession number(s). The sequences of the additional French Polynesian isolates have been submitted to GenBank under accession no.
KX447509 to KX447521.
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